Basics |
Caribou Biosciences, Inc.
|
IPO Date: |
July 23, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$149.74M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.27 | 3.73%
|
Avg Daily Range (30 D): |
$0.07 | 4.68%
|
Avg Daily Range (90 D): |
$0.06 | 5.01%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.07M |
Avg Daily Volume (30 D): |
1.5M |
Avg Daily Volume (90 D): |
1.13M |
Trade Size |
Avg Trade Size (Sh.): |
137 |
Avg Trade Size (Sh.) (30 D): |
254 |
Avg Trade Size (Sh.) (90 D): |
236 |
Institutional Trades |
Total Inst.Trades: |
504 |
Avg Inst. Trade: |
$1.76M |
Avg Inst. Trade (30 D): |
$3.78M |
Avg Inst. Trade (90 D): |
$3.78M |
Avg Inst. Trade Volume: |
.28M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.87M |
Avg Closing Trade (30 D): |
$9.15M |
Avg Closing Trade (90 D): |
$9.15M |
Avg Closing Volume: |
301.18K |
|
|
News |
May 6, 2025 @ 8:00 PM
Caribou Biosciences to Participate in the BofA Sec...
Source: N/A
|
Feb 22, 2025 @ 2:19 PM
CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSE...
Source: N/A
|
Feb 19, 2025 @ 9:00 PM
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 16, 2025 @ 2:15 PM
CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTO...
Source: N/A
|
Feb 13, 2025 @ 10:46 PM
CRBU DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, En...
Source: N/A
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-1.62
|
$-.43
|
$-.39
|
Diluted EPS
|
$-1.62
|
$-.43
|
$-.39
|
Revenue
|
$ 9.92M
|
$ 2.35M
|
$ 2.08M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -147.86M
|
$ -39.99M
|
$ -35.49M
|
Operating Income / Loss
|
$ -163.53M
|
$ -42.91M
|
$ -38.88M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -19.98M
|
$ 13.12M
|
$ -15.68M
|
PE Ratio
|
|
|
|
|
|
|